Biotechnology Fund Class Fund Manager Performance Evaluation
| RYOAX Fund | USD 64.45 10.45 19.35% |
The fund shows a Beta (market volatility) of 0.18, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Biotechnology Fund's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biotechnology Fund is expected to be smaller as well.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Biotechnology Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
...more| Expense Ratio Date | 19th of August 2022 | |
| Expense Ratio | 1.6500 |
Biotechnology |
Biotechnology Fund Relative Risk vs. Return Landscape
If you would invest 6,714 in Biotechnology Fund Class on September 18, 2024 and sell it today you would lose (269.00) from holding Biotechnology Fund Class or give up 4.01% of portfolio value over 90 days. Biotechnology Fund Class is currently producing negative expected returns and takes up 3.3897% volatility of returns over 90 trading days. Put another way, 30% of traded mutual funds are less volatile than Biotechnology, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Biotechnology Fund Current Valuation
Fairly Valued
Today
Please note that Biotechnology Fund's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Biotechnology Fund Class shows a prevailing Real Value of $63.56 per share. The current price of the fund is $64.45. We determine the value of Biotechnology Fund Class from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Biotechnology Fund is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotechnology Mutual Fund. However, Biotechnology Fund's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 64.45 | Real 63.56 | Hype 64.45 |
The intrinsic value of Biotechnology Fund's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotechnology Fund's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biotechnology Fund Class helps investors to forecast how Biotechnology mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotechnology Fund more accurately as focusing exclusively on Biotechnology Fund's fundamentals will not take into account other important factors: Biotechnology Fund Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotechnology Fund's investment risk. Standard deviation is the most common way to measure market volatility of mutual funds, such as Biotechnology Fund Class, and traders can use it to determine the average amount a Biotechnology Fund's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0027
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RYOAX |
Estimated Market Risk
| 3.39 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Biotechnology Fund is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biotechnology Fund by adding Biotechnology Fund to a well-diversified portfolio.
Biotechnology Fund Fundamentals Growth
Biotechnology Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Biotechnology Fund, and Biotechnology Fund fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biotechnology Mutual Fund performance.
| Price To Earning | 18.21 X | ||||
| Price To Book | 3.49 X | ||||
| Price To Sales | 4.68 X | ||||
| Total Asset | 5.79 M | ||||
About Biotechnology Fund Performance
Evaluating Biotechnology Fund's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Biotechnology Fund has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biotechnology Fund has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.Things to note about Biotechnology Fund Class performance evaluation
Checking the ongoing alerts about Biotechnology Fund for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Biotechnology Fund Class help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biotechnology Fund generated a negative expected return over the last 90 days | |
| Biotechnology Fund has high historical volatility and very poor performance | |
| The fund generated three year return of -1.0% | |
| Biotechnology Fund Class maintains 99.51% of its assets in stocks |
- Analyzing Biotechnology Fund's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biotechnology Fund's stock is overvalued or undervalued compared to its peers.
- Examining Biotechnology Fund's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biotechnology Fund's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biotechnology Fund's management team can help you assess the Mutual Fund's leadership.
- Pay attention to analyst opinions and ratings of Biotechnology Fund's mutual fund. These opinions can provide insight into Biotechnology Fund's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Transaction History View history of all your transactions and understand their impact on performance |